Patents (1430 Stem Cell Patents)

Stromal antigen-presenting cells and use thereof

Mesenchymal stem cells are known to possess a variety of immune modulatory activities such as suppression of allogeneic responses, as well as induction of T regulatory cells.  Mechanisms include expression of IDO and HLA-G.  Mesenchymal stem cells have been demonstrated effective in patients with heart failure and are clinically in trials for graft versus host disease.

The current patent teaches the use of mesenchymal... [Read more]

LATEST STEM CELL PATENTS

Dedifferentiated, programmable stem cells of monocytic origin, and their production and use

2 days ago

This patent is a continuation of Blasticon's #7,138,275 covering a monocyte-derived stem cell that is capable of differentiating into islets, hepatocytes, and neurons.  In the current patent the use of hepatic, or hepatic-like cells derived from these monocytes is covered.

The general coverage of the patent extends to generation and use of a cell capable of expressing albumin that is made by the differentiation of a CD-14 positive, CD-90 positive monocytic derived stem cell.

Covered uses including treatment of cirrhosis... [Read more]

Directed in vitro differentiation of marrow stromal cells into neural cell progenitors

June 17th

This patent covers the generation of neurons from mesenchymal stem cells, or like the inventor calls them "mesenchymal stromal cells", which is the more politically correct way of naming them.

Very broad claims are issued, the first one being: "A method of producing a neural progenitor cell, said method comprising contacting an isolated bone marrow stromal cell with a compound that induces differentiation of said bone marrow stromal cell, wherein the compound is a cyclic AMP-stimulating compound that increases the... [Read more]

Progenitor cells from wharton's jelly of human umbilical cord

June 17th

This patent covers methods of extracting an adherent mesenchymal-like stem cells from the Wharton's Jelly of the umbilical cord.  The extracted cells are negative for MHC and are termed by the inventors human umbilical cord perivascular (HUCPV) cells.  In the examples section the the cells are demonstrated to be capable of differentiating into osteocytes, chondrocytes, adipocytes, and myocytes.

The first independent claim covers "A method of obtaining a population of human umbilical cord perivascular (HUCPV) cells, comprising: (a) obtaining an excised blood vessel... [Read more]

View all stem cell patents

RECENTLY ADDED STEM CELL PATENTS
Patents added 1 day ago. Patents added 2 days ago. Patents added June 17th. Patents added June 8th. Patents added May 26th. Patents added May 16th. Patents added May 12th. Patents added May 5th. Patents added May 4th. Patents added April 27th. Patents added April 20th. Patents added April 14th. View all 1430 stem cell patents





Home | News | Patents | Products | Jobs | Links | Search | Journal | RSS

About | Advisory Board | Newsletter | Advertise | Contact | Sitemap | Privacy Policy | Terms of Use

Copyright © 2006 - 2009 StemCellPatents.com - All rights reserved. - Toronto Web Design

StemCellPatents.com V2.03